Mizuho Securities Maintains Biogen(BIIB.US) With Buy Rating

Futu News15:32 · Ratings

Sage To Resume Full Ownership Of SAGE-324 Program As Biogen Terminates Collaboration Deal

RTTNewsSep 26 20:10

Sage Therapeutics, Biogen End Licensing Agreement for Tremor Drug

WSJSep 26 19:28

Biogen to End Sage Deal for Neuro Candidate

Seeking AlphaSep 26 19:20

Express News | Sage Therapeutics Announces Discontinuation of the Collaboration With Biogen on the Sage-324 Program

BreakingsSep 26 19:00

Sage Therapeutics Announces Discontinuation of the Collaboration With Biogen on the SAGE-324 Program

BusinesswireSep 26 19:00